| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10071054 | RESILIA PHARMS | Econazole composition and methods of treatment therewith |
Aug, 2031
(7 years from now) | |
Ecoza is owned by Resilia Pharms.
Ecoza contains Econazole Nitrate.
Ecoza has a total of 1 drug patent out of which 0 drug patents have expired.
Ecoza was authorised for market use on 24 October, 2013.
Ecoza is available in aerosol, foam;topical dosage forms.
The generics of Ecoza are possible to be released after 08 August, 2031.
Drugs and Companies using ECONAZOLE NITRATE ingredient
Market Authorisation Date: 24 October, 2013
Treatment: NA
Dosage: AEROSOL, FOAM;TOPICAL
More Information on Dosage
ECOZA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic